The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function.
暂无分享,去创建一个
[1] J. Ortaldo,et al. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. , 2000, Immunity.
[2] B. Blom,et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. , 2000, Immunity.
[3] A. Ullrich,et al. Association of signal‐regulatory proteins β with KARAP/DAP‐12 , 2000 .
[4] Leena Peltonen,et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts , 2000, Nature Genetics.
[5] C. Lagenaur,et al. Role of CD47 as a marker of self on red blood cells. , 2000, Science.
[6] P. Love,et al. ITAM multiplicity and thymocyte selection: how low can you go? , 2000, Immunity.
[7] M. Colonna,et al. Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.
[8] J. Ortaldo,et al. Interaction of Ly-49D+ NK Cells with H-2Dd Target Cells Leads to Dap-12 Phosphorylation and IFN-γ Secretion1 , 2000, The Journal of Immunology.
[9] M. Colonna,et al. Cutting Edge: Signal-Regulatory Protein β1 Is a DAP12-Associated Activating Receptor Expressed in Myeloid Cells1 , 2000, The Journal of Immunology.
[10] L. Lanier,et al. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Anderson,et al. Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H , 1999, Journal of leukocyte biology.
[12] Eric O Long,et al. Regulation of immune responses through inhibitory receptors. , 1999, Annual review of immunology.
[13] D. Gautheret,et al. Gene Structure, Expression Pattern, and Biological Activity of Mouse Killer Cell Activating Receptor-associated Protein (KARAP)/DAP-12* , 1998, The Journal of Biological Chemistry.
[14] W. Seaman,et al. DAP12-mediated Signal Transduction in Natural Killer Cells , 1998, The Journal of Biological Chemistry.
[15] E. Ullu,et al. MFR, a Putative Receptor Mediating the Fusion of Macrophages , 1998, Molecular and Cellular Biology.
[16] A. Weiss,et al. The Syk family of protein tyrosine kinases in T‐cell activation and development , 1998, Immunological reviews.
[17] S. Latour,et al. High Expression of Inhibitory Receptor SHPS-1 and Its Association with Protein-tyrosine Phosphatase SHP-1 in Macrophages* , 1998, The Journal of Biological Chemistry.
[18] T. K. van den Berg,et al. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. , 1998, Journal of immunology.
[19] B. Neel,et al. Identification of Major Binding Proteins and Substrates for the SH2-Containing Protein Tyrosine Phosphatase SHP-1 in Macrophages , 1998, Molecular and Cellular Biology.
[20] L. Lanier,et al. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. , 1998, Journal of immunology.
[21] L. Moretta,et al. NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis , 1998, The Journal of experimental medicine.
[22] Jun Wu,et al. Association of DAP12 with activating CD94/NKG2C NK cell receptors. , 1998, Immunity.
[23] S. Anderson,et al. Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. , 1998, Journal of immunology.
[24] Jun Wu,et al. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells , 1998, Nature.
[25] M. Colonna,et al. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex , 1998, European journal of immunology.
[26] L. Peltonen,et al. Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13. , 1998, American journal of human genetics.
[27] P. Maquet,et al. Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia. , 1997, Journal of medical genetics.
[28] É. Vivier,et al. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. , 1997, Journal of immunology.
[29] A. Ullrich,et al. A family of proteins that inhibit signalling through tyrosine kinase receptors , 1997, Nature.
[30] R. Biassoni,et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation , 1996, European journal of immunology.
[31] L. Moretta,et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.
[32] M. Reth. Antigen receptor tail clue , 1989, Nature.